"How is it going to help?": Exploring Black breast cancer patients' questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy.

Head, Katharine J; Hayes, Lisa R; Miller, Nadia E; Shakil, Safia; Bales, Casey L; Schneider, Bryan P

Head, Katharine J; Hayes, Lisa R; Miller, Nadia E; Shakil, Safia; Bales, Casey L; Schneider, Bryan P.

Afiliação

Head KJ; Department of Communication Studies, 425 University Blvd, Indiana University-Purdue University Indianapolis, IN, 46202, United States.
Hayes LR; Pink-4-Ever Ending Disparities, 8770 Commerce Park Place F, Indianapolis, IN 46286, United States.
Miller NE; Pink-4-Ever Ending Disparities, 8770 Commerce Park Place F, Indianapolis, IN 46286, United States.
Shakil S; Department of Biomedical Engineering, 425 University Blvd, Indiana University-Purdue University Indianapolis, IN 46202, United States.
Bales CL; Department of Medicine-Division of Clinical Pharmacology, 950 West Walnut Street, Rm 402 Research Institute II (R2), Indianapolis, IN 46202, United States.
Schneider BP; Department of Medicine-Division of Hematology/Oncology, Indiana Cancer Pavilion, 535 Barnhill Drive - 473, Indianapolis, IN 46202, United States.

PEC Innov ; 2: 100118, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37214510